Sign in
CompletedNo phase

Early Feasibility Study of the Neovasc Tiara™ Mitral Valve System

Key facts

Who runs it
Shockwave Medical, Inc.
Where
Chicago, Detroit, Los Angeles, New York, Seattle, and St Louis, United StatesSee the 6 sitesAlso in 2 other countries, 4 sites
Trial code
Status
Completed
People taking part
27 people enrolled
Started
5 Feb 2015
Ended
9 Dec 2024
Type of study
Interventional
Treatments tested
  • Mitral valve replacement
Record updated
24 July 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • Severe symptomatic mitral regurgitation (Stage D)
  • High surgical risk for open mitral valve surgery
  • Subject meets the anatomical eligibility criteria for available size(s)
  • NYHA Class III or IV heart failure

Who cannot take part

  • DMR deemed by the heart team to be operable
  • Prohibitive risk, deemed too frail or listed for cardiac transplant
  • Unsuitable cardiac structure

Where in United States

Also in 2 other countries, 4 sites

  • Northwestern UniversityChicago, United States
  • Henry Ford Health SystemDetroit, United States
  • Cedars-Sinai Medical CenterLos Angeles, United States
  • Columbia University Medical CenterNew York, United States
  • University of Washington Medical CenterSeattle, United States
  • Washington UniversitySt Louis, United States

About the trial

What the trial wants to find out

The purpose of this study is to evaluate the safety and initial performance of the Neovasc Tiara Mitral Transcatheter Heart Valve with the Tiara Transapical Delivery System.

The group in the trial

  • TreatmentTreatment being tested

    Transcatheter mitral valve replacement with the TIARA valve and transapical delivery system

    Treatment: Mitral valve replacement

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Early Feasibility Study of the Neovasc Tiara™ Mitral Transcatheter Heart Valve With the Tiara™ Transapical Delivery System
Record updated
24 July 2026